Diabetes

By Laura Lovett 03:15 pm June 15, 2020
This morning Abbott revealed that its much anticipated integrated continuous glucose monitoring system the FreeStyle Libre 2 is now FDA cleared for adults and kids over the age of 4 with diabetes.  The latest product is able to continuously transmit glucose data every minute, and users can set the system to send alarms when their glucose is too high or too low. Previously users had to scan the...
By Dave Muoio 02:37 pm June 15, 2020
The American Diabetes Association's 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers and service providers highlighted new data as part of the virtual clinical conference. Read on for summaries of the studies and findings, as well as links to the online abstracts. Onduo Verily-backed diabetes management service Onduo, which combines a mobile app...
By Mallory Hackett 09:54 am June 9, 2020
A new study published in US Endocrinology found Abbott’s continuous glucose monitoring system, the FreeStyle Libre, demonstrated significant cost savings for diabetic care compared to traditional fingerstick testing.  Abbott’s system uses flash continuous glucose monitoring (CGM) through a sensor placed to the back of the upper arm, and lasts for up to 14 days. The device automatically collects...
By Dave Muoio 02:51 pm June 3, 2020
WellDoc's BlueStar chronic disease-management tool has picked up another 510(k) FDA clearance that will allow it to support adult Type 2 diabetes patients using long-acting basal insulin. The feature was announced by WellDoc this morning, but cleared by the agency in April, according to a listing on its website. The new capability takes the form of a new program within the prescription BlueStar...
By Laura Lovett 01:55 pm June 3, 2020
This morning Bigfoot Biomedical, a diabetes startup focused on automating insulin delivery through a connected insulin pen, picked up an extra $10 million Series C funding, closing the round at $55 million. Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders.  When the first $45 million...
By Dave Muoio 02:55 pm April 27, 2020
Implementation of either an automated or semi-automated deep learning system for diabetic retinopathy screening could lead to cost savings at the health-system level, according to an economic analysis modeling study recently published in The Lancet Digital Health. Backed by Singapore's Ministry of Health, the investigation looked at data from a national diabetic retinopathy screening program...

Credit: Sehat Kahani

By Leontina Postelnicu 09:43 am March 13, 2020
A nation of over 200 million citizens, Pakistan is a major player in South Asia, with a large population to care for. Like many countries around the world, it is struggling to address the shortage of doctors and prevalence of chronic diseases while ensuring access to affordable medicine. But where there are challenges, there is also room for innovation. Today, we are seeing entrepreneurs and...
By Dave Muoio 04:06 pm March 12, 2020
Together in perfect harmony. Dexcom and Welldoc have kicked off a new collaboration that will provide Dexcom G6 continuous glucose monitor users with data-analysis insights from Welldoc's digital diabetes management product, BlueStar. These insights include information on how lifestyle factors such as activity, nutrition, sleep and medication adherence are affecting a user's glucose levels. “Now...
By Dave Muoio 02:26 pm March 3, 2020
It was another strong quarter for the ever-growing Livongo Health, which yesterday reported to investors a 137% rise in year-over-year Q4 revenue from $21.2 million to $50.2 million. Full-year revenues followed a similar path, growing 149% from $68.4 million in 2018 to $169.9 million in 2019. “Livongo finished the year with excellent momentum, exceeding all of our guidance metrics, achieving...
By Dave Muoio 03:22 pm February 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...